Skip to main content
. 2021 Feb 19;15:90. doi: 10.1186/s13256-020-02598-0

Fig. 1.

Fig. 1

Clinical course: blood laboratory values from initial baseline assessment through 30 days post CAR T cell administration. LDC was administered on days -47 and days -5 through -3; positive COVID-19 test by PCR day -46, negative COVID-19 test by PCR day -7; CAR T cell administration day 1, anti-viral antibody titer day -7. Repeat anti-viral antibody titers were conducted day 43 and day 73 (not shown)